Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’...
Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’s disease
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Early diagnosis of dementia including Alzheimer’s disease (AD) is an urgent medical and welfare issue. However, to date, no simple biometrics have been available. We reported that blood DNA methylation levels of the
COASY
gene, which encodes coenzyme A synthase, were increased in individuals with AD and amnestic mild cognitive impairment (aMC...
Alternative Titles
Full title
Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’s disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7376092
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7376092
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-020-69248-9
